LY9 and hepatocellular carcinoma: Analysis of SLAMF3 mRNA in samples demonstrated that in nine samples (9/13, 70%), SLAMF3 mRNA in HCC (T) tissues was significantly lower than those of adjacent normal tissue (pT) (Figure 6A and Supplementary Figure 3A; p < 0.005).